New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
11:07 EDTEWEdwards Lifesciences backs FY14 EPS view 'around' $3.10, consensus $3.17
Sees FY14 total net sales growth 1%-10%. Sees FY14 gross profit margin approximately 73%. Sees FY14 free cash flow $325M-$425M. Guidance provided in slides presentation for William Blair & Company LLC Growth Stock Conference.
News For EW From The Last 14 Days
Check below for free stories on EW the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
16:18 EDTEWEdwards Lifesciences sees Q3 EPS 66c-72c, consensus 74c
Subscribe for More Information
16:17 EDTEWEdwards Lifesciences raises 2014 EPS outlook to $3.24-$3.34, consensus $3.19
Subscribe for More Information
16:16 EDTEWEdwards Lifesciences reports Q2 EPS 88c, consensus 77c
Reports Q2 revenue $575.1M, consensus $544.3M.
15:53 EDTEWNotable companies reporting after market close
Subscribe for More Information
July 28, 2014
11:07 EDTEWLeerink medical devices analyst holds an analyst/industry conference call
Medical Devices Analyst Antalffy, along with MEDACorp Specialist Arie Pieter Kappetein, MD, PhD and Bernhard Meier, MD, assess EU cardiology trends on an Analyst/Industry conference call to be held on July 31 at 3 pm.
July 22, 2014
07:57 EDTEWHouse Energy & Commerce Committee to hold a hearing
The Subcommittee on Health holds a hearing entitled, "21st Century Cures: Examining Barriers to Ongoing Evidence Development and Communication" with CEO Mussallem at Edwards Lifesciences on July 22 at 3 pm. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use